L-HISTIDINE, N-.BETA.-ALANYL-, ZINC COMPLEX
Castration-resistant Prostate Cancer
Jiangnan UniversitySmall moleculePhase 1/2Dormant
CCC
48/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 37/ 100
- Competitive Position
- 81/ 100
Competitive context
31 Active assets in the Castration-resistant Prostate Cancer cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
PREDNISONE TABLETS Sichuan Baili Pharmaceutical Co., Ltd. | Phase 4 | BBB |
RADIUM RA-223 Bayer | Phase 4 | BB |
Abiraterone Acetate AstraZeneca | Phase 4 | BB |
Zoladex Bayer | Phase 3 | BB |
Seviteronel Innocrin Pharmaceutical | Phase 2 | BB |
View all 50 →
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →